Clinical Trial Update: Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether renin-angiotensin system blockers slow progression of chronic kidney disease in elderly patients with non-prote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Angiotensin II receptor blockers (ARBs) (Angiotensin II receptor blockers)
• Angiotensin-converting enzyme inhibitors (ACE inhibitors) (ACE inhibitors)

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Renal Insufficiency, Chronic, Proteinuria | Phase 4 | Status: UNKNOWN